To include your compound in the COVID-19 Resource Center, submit it here.

Saints marches in

Secondary investor Saints Capital snaps up 9 Oxford Bioscience plays

Saints marches in

Secondary investment firm Saints Capital did a deal last week with early stage life sciences VC Oxford Bioscience Partners that will give Oxford some immediate liquidity for a couple of older funds and allow it to

Read the full 387 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers